Biotech · Private company
Theratechnologies
Track this companyFree. Adds Theratechnologies to your Dealase workspace and tells you when its record changes.
Clinical trials51 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- TesamorelinPhase 3 · LipodystrophyClinicalTrials.gov · fetched Nov 12, 2026
- TH1902Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- Diagnostic TestHIVClinicalTrials.gov · fetched Nov 12, 2026
- HIV Anti-retroviral Background TherapyHIVClinicalTrials.gov · fetched Nov 12, 2026
- No ibalizumab or Pre-ibalizumab treatmentHIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- On ibalizumab treatmentHIV InfectionsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials5
- External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERACOMPLETED · started Aug 5, 2022ClinicalTrials.gov NCT05495204 · fetched Nov 12, 2026
- The Visceral Adiposity Measurement and Observation StudyCOMPLETED · started Apr 18, 2022ClinicalTrials.gov NCT05383456 · fetched Nov 12, 2026
- A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes With and Without IbalizumabCOMPLETED · started Mar 22, 2022ClinicalTrials.gov NCT05388474 · fetched Nov 12, 2026
- TH1902 in Patients With Advanced Solid TumorsPHASE1 · ACTIVE_NOT_RECRUITING · started Mar 4, 2021ClinicalTrials.gov NCT04706962 · fetched Nov 12, 2026
- TH9507 Extension Study in Patients With HIV-Associated LipodystrophyPHASE3 · COMPLETED · started Aug 1, 2007ClinicalTrials.gov NCT00608023 · fetched Nov 12, 2026